European Disease Progression Monitor: Edition 4

COVID-19 disease progression monitor

EU Disease-progression-review

Italy, Spain and France past COVID-19 peak

Germany and U.K. later peaks than EU

latest death rate in EU

EU5 past COVID-19 peak intensity

COVID-19 treatments and preventative therapies

disease progression monitor disclaimer

For more information, please visit lek.com/covid19 or fill out this form to get in touch.

Other editions in this series:
European Disease progression monitor: Edition III

Related Insights

Digital

AI Has Moved Beyond Hype — It Is Driving Performance and Deployment Is Widespread

September 20, 2023

Executive Insights

Life Sciences & Pharma

Cash Preservation in the Biopharmaceutical Industry: Navigating Uncertainty

June 22, 2023

Healthcare Services

The LatAm Digital Landscape in Healthcare: Where Are the Opportunities Today?

April 25, 2023

Executive Insights

Biotech and Pharmaceuticals

Shareholder Value Creation for First-Time Launchers: Two Decades of Learnings

December 30, 2022

Executive Insights

Biotech and Pharmaceuticals

Building Clinical Trial Leadership in Biopharma

October 5, 2022

Executive Insights

Sustainability

From Commitment to Reality: Overcoming the Corporate Sustainability Struggle

October 4, 2022